{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Indoleamine 2,3-dioxygenase based immunotherapy", "item": "https://www.patentleaderboard.com/patent/11324813"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Indoleamine 2,3-dioxygenase based immunotherapy

Indoleamine 2,3-dioxygenase based immunotherapy

US Patent 11324813 · Granted May 10, 2022

Estimated economic value: $6,077,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Indoleamine 2,3-dioxygenase based immunotherapy2025
Indoleamine 2,3-dioxygenase based immunotherapy2025
Immunogenic arginase 2 polypeptides2025
PDL2 compounds2025
ARGINASE1 polypeptides2025
PDL1 peptides for use in cancer vaccines2025
Immunogenic arginase peptides2024
Vaccine compositions comprising tryptophan 2,3-dioxygenase or fragments thereof2024
Indoleamine 2,3-dioxygenase based immunotherapy2023
Indoleamine 2,3-dioxygenase based immunotherapy2023
PDL2 compounds2022
Vaccine compositions comprising C—C motif chemokine 22 (CCL22) or fragments ther2022